PL
JAZZ icon

Perpetual Ltd’s Jazz Pharmaceuticals JAZZ Stock Holding History

Perpetual Ltd’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Sell
104,264
-36,621
-26% -$8.02M 0.36% 82
2026
Q1 		$26.6M Sell
140,885
-13,765
-9% -$2.41M 0.41% 65
2025
Q4 		$26.3M Sell
154,650
-447,997
-74% -$68.7M 0.38% 66
2025
Q3 		$79.4M Sell
602,647
-284,936
-32% -$34.2M 0.99% 30
2025
Q2 		$94.2M Sell
887,583
-64,589
-7% -$7.02M 1.11% 25
2025
Q1 		$118M Buy
952,172
+357,784
+60% +$46.7M 1.43% 19
2024
Q4 		$73.2M Sell
594,388
-81,043
-12% -$9.55M 0.86% 42
2024
Q3 		$75.2M Buy
675,431
+63,564
+10% +$6.97M 0.82% 44
2024
Q2 		$65.3M Buy
611,867
+136,849
+29% +$15M 0.71% 51
2024
Q1 		$57.2M Buy
475,018
+166,543
+54% +$20.4M 0.56% 55
2023
Q4 		$37.9M Buy
308,475
+80,775
+35% +$10.1M 0.39% 59
2023
Q3 		$29.5M Buy
227,700
+155,325
+215% +$20.7M 0.3% 68
2023
Q2 		$8.97M Buy
+72,375
New +$9.74M 0.08% 147

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Perpetual Ltd's JAZZ Position: Q2 2026 in Review

Perpetual Ltd reduced its Jazz Pharmaceuticals (JAZZ) stake by 26% in Q2 2026, selling an estimated $8.02M and leaving 104,264 shares worth $25.1M. The position accounts for 0.36% of the portfolio, ranked #82.

Perpetual Ltd first reported a position in JAZZ in Q2 2023 and has held it in 13 quarters since. The position peaked at $118M in Q1 2025. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Perpetual Ltd held 104,264 shares of Jazz Pharmaceuticals worth $25.1M as of Q2 2026.
  • Perpetual Ltd sold 36,621 Jazz Pharmaceuticals shares in Q2 2026, an estimated $8.02M.
  • Jazz Pharmaceuticals made up 0.36% of Perpetual Ltd's portfolio in Q2 2026, its #82 holding.
  • Perpetual Ltd first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • Perpetual Ltd's Jazz Pharmaceuticals position peaked at $118M in Q1 2025.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.